Fig. 5 | Scientific Reports

Fig. 5

From: Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC

Fig. 5

Assessment of the ICI treatment effect based on the prognostic signature. (A) scatter plot shows that the mortality rate of patients increases with higher risk in GSE14520. (B) risk curve displays the distribution characteristics of the risk scores in GSE14520. (C) survival curve for the risk scores calculated by the prognostic signature in GSE14520. (D) The ROC curve of the risk score and clinical relevant features in GSE14520. (E) Distribution of TIDE scores, with each vertical bar representing a patient; red indicates patients who responded to ICI treatment, while blue indicates patients who did not respond to ICI treatment. (F) Violin plot of the TIDE scores. (G) Violin plot for exclusion. (H) Violin plot for MSI. **** means P < 0.0001.

Back to article page